The participants will receive metformin 500mg 3times per day for 3months and one month is left for spontaneous pregnancy to occur or not (primary outcome ) and the investigators will check endometrial thickness and subendometerial vascularity as markers of endometrial receptivity before and after the treatment.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
85
Metformin to increase pregnancy rate in polycystic ovarian syndrome patients
Ain Shams University Maternity Hospital
Cairo, Egypt
pregnancy
polycystic ovarian syndrome patients getting pregnant on receiving Metformin
Time frame: 4 months
Endometrial thickness and Sub Endometrial vascularity
Endometrial thickness and Sub Endometrial vascularity before and after receiving Metformin as markers of endometrial receptivity
Time frame: 4 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.